Physician profile
Fernando Suarez
NPI 1619297975
$728.37
in general payments reported to CMS, 2019-2025
14 companies · $34.04 in 2025
The $34.04 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $129 · 2021: $184 · 2022: $121 · 2023: $201 · 2024: $59.58 · 2025: $34.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $283.24 | 2020-2023 | Bexsero |
| Pfizer INC. | $77.62 | 2021-2023 | |
| Sobi, INC | $52.97 | 2020-2021 | |
| Cranial Technologies, INC | $48.75 | 2021-2023 | Doc Band |
| Kaleo, INC. | $41.20 | 2022 | |
| Sanofi Pasteur INC. | $40.48 | 2022 | |
| Inspire Medical Systems, INC. | $34.04 | 2025 | Inspire |
| Exact Sciences Corporation | $32.50 | 2024 | Cologuard Collection Kit |
| Phadia US INC. | $27.08 | 2024 | Immunocap |
| Oxford Immunotec USA INC | $23.94 | 2021 | |
| Merck Sharp & Dohme LLC | $21.05 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $19.09 | 2023 | Kristalose |
| Genentech USA, INC. | $13.47 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.